Back to 
SCHRODER INVESTMENT MANAGEMENT GROUP
SCHRODER INVESTMENT MANAGEMENT GROUP
MCRB
Showing 0 of 12 quarters
Position history for SCHRODER INVESTMENT MANAGEMENT GROUP's holdings in SERES THERAPEUTICS INC
No. Schroder Investment Management Group exited its MCRB (Seres Therapeutics) position in Q3 2021. Its Q2 2021 13F listed 98,432 shares worth $2.3M. Schroder Investment Management Group already held MCRB in its Q4 2018 13F, the earliest on record, and held it in 11 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.